US11946099B2ActiveUtilityA1
Elimination of primer-primer interactions during primer extension
Assignee: ROCHE SEQUENCING SOLUTIONS INCPriority: Feb 25, 2016Filed: Feb 23, 2021Granted: Apr 2, 2024
Est. expiryFeb 25, 2036(~9.6 yrs left)· nominal 20-yr term from priority
Inventors:Brian Christopher Godwin
C12Q 1/6848C12Q 1/6806C12Q 1/6809C12Q 1/6811C12Q 1/6855C12Q 1/686C12Q 2525/101C12Q 2525/186
69
PatentIndex Score
0
Cited by
1
References
10
Claims
Abstract
The invention comprises a method of amplifying nucleic acids by primer extension with reduced formation of primer-primer byproducts.
Claims
exact text as granted — not AI-modifiedThe invention claimed is:
1. A method of amplifying a target nucleic acid in a sample with reduced primer-primer interaction comprising:
(a) a primer extension step, wherein the sample is contacted with: (i) a nucleic acid polymerase, and (ii) a first primer which is a single-stranded oligonucleotide comprising at least one modified nucleotide that stalls nucleotide incorporation by the polymerase, the first primer comprising two arms complementary to a target sequence separated by a linker sequence non-complementary to the target sequence, such that a gap is created between the ends of the two arms when the first primer hybridizes to the target nucleic acid, wherein the polymerase fills the gap between the ends of the two arms; and
(b) an exponential amplification step wherein the sample is contacted with a second primer complementary to the primer extension product and a polymerase tolerant of the modified nucleotide.
2. The method of claim 1 , wherein the first primer comprises binding sites for universal amplification primers and the second primer is a universal primer.
3. The method of claim 1 , wherein the modified nucleotide is uracil.
4. A reaction mixture for synthesizing nucleic acid strands according to claim 1 , comprising a target nucleic acid, a nucleic acid polymerase and a first primer which is a single-stranded oligonucleotide consisting of two arms complementary to a target sequence separated by a linker sequence non-complementary to the target sequence and comprising at least one modified nucleotide that stalls nucleotide incorporation by the polymerase.
5. The method of claim 1 , further comprising a step of joining the ends of the extended first primer by ligation.
6. The method of claim 5 , further comprising prior to step (b), contacting the sample with an endonuclease.
7. The method of claim 1 , wherein the first primer comprises a unique molecular barcode.
8. The method of claim 1 , wherein the second primer comprises a sample barcode.
9. The method of claim 1 , further comprising sequencing the amplified nucleic acid from step (b).
10. The method of claim 9 , wherein a universal sequencing primer site is located in the second primer.Cited by (0)
No later patents cite this yet.
References (0)
No backward citations on record.